Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference27 articles.
1. Globocan 2012 — Home n.d. http://globocan.iarc.fr/Default.aspx. [Accessed 10 October 2016].
2. Type 2 diabetes and risk of pancreatic adenocarcinoma;J. Clin. Oncol.,2013
3. Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study;Johnson;J. Clin. Oncol.,2013
4. Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study;Llovet;J. Clin. Oncol.,2013
5. Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial;Zhu;JAMA,2014
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival;Cancer Medicine;2023-12
2. Outcomes in elderly patients undergoing hepatic resection compared to ablative therapy for hepatocellular carcinoma;Journal of Surgical Oncology;2023-06-08
3. Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma;Frontiers in Oncology;2022-08-02
4. Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress;Toxicology and Applied Pharmacology;2022-07
5. The characteristics of patients with macrovascular invasion in hepatocellular carcinoma: when East meets West;Langenbeck's Archives of Surgery;2021-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3